While this sensitizing effect is IFNγ(-R1)-dependent, it does not preclude the cell-intrinsic secondary effects of IFNγ signaling, such as MHC class I upregulation or any of the other anti-tumor effects that have been reported for IFNγ signaling24–27. This evidence concerns the gene IFNG and neoplasm.